Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Myeloproliferative Disorders 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Radiosurgery 27Blood Specimen Collection 20Drug Therapy 18Radiotherapy 14Early Intervention, Educational 14Magnetic Resonance Spectroscopy 13Standard of Care 12Pemetrexed 12Carboplatin 12Exercise 11Practice Guidelines as Topic 9X-Rays 8Psychiatric Rehabilitation 8Methods 8Immunotherapy 8Therapeutics 7Surgical Procedures, Operative 7Paclitaxel 7Fluorodeoxyglucose F18 7Surveys and Questionnaires 6Counseling 6Cisplatin 6Biopsy 6Anterior Temporal Lobectomy 6Thoracic Surgery, Video-Assisted 5Liquid Biopsy 5Gemcitabine 5Erlotinib Hydrochloride 5Docetaxel 5Bevacizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Non-Small-Cell Lung × Drug Screening Assays, Antitumor × Clear all
NCT00305617 2011-05-17

Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer

The Cleveland Clinic

Phase NA Completed
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡